Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, April 16, 2025 /PRNewswire/ -- Equity Insider News Commentary - The potential ...

With the introduction of a subcutaneous formulation, ENTYVIO has expanded patient convenience and global accessibility. Continued growth is supported by rising IBD prevalence and ongoing geographic ...

The market is characterized by trends such as personalized medicine, targeted therapies, and combination treatments. Key players include Eli Lilly, Bristol Myers Squibb, and AstraZeneca. As North ...

U.S. researchers are about to test if livers from gene-edited pigs could treat people with sudden liver failure — not with a transplant but temporarily attached outside the body.

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today a settlement and license agreement with ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

During the upcoming Abu Dhabi Global Health Week (ADGHW), a global initiative aimed at advancing longevity science and precision medicine will be released, expected to set a new standard for ...

Rein advanced the clinical development of its lead asset, LTI-03, and aims to initiate a Phase 2 trial for the treatment of idiopathic pulmonary f ...

(Reuters) -AbbVie on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition-related expenses. The company expects adjusted profit in the range of ...

Cadence today announced that Great Place To Work® and Fortune magazine have recognized Cadence as one of the Fortune 100 Best Companies to Work For® in 2025. This year marks the 11th time Cadence has ...